코스모진텍

비상장계속사업자

Cosmo Genetech Co., LTD.

마상혁

Investment Review Report

Auto-filled from disclosures & public data + AI-drafted analysis. Edit, then export to PDF/DOCX.

Editor

1.Deal Terms

2.Valuation / Exit Assumptions

Exit Scenarios100M KRW

3.Fund Eligibility

Fund mandate eligibility — no data, enter manually

Enter fund mandate requirements and applicability (Y/N) to include a table in the report.

4.Capital Changes

Not in DART — enter capital-raise history manually

Enter capital changes such as founding capital and paid-in increases.

5.Stock Options

Enter manually

Enter stock option grant history.

6.Investment Highlights

AI draft — editable

Click 'Generate AI draft' to populate data-grounded investment highlights.

7.Investment Risks

AI draft — editable

Risks are populated after 'Generate AI draft'.

8.Market Analysis

AI draft — editable

9.Business Analysis

AI draft — editable

10.Conclusion (Investment Opinion)

AI draft — editable

11.P&L Projection

Analyst estimates, manual entry (100M KRW). Generates a trend chart & table.

Enter projected revenue / op. profit / net income (100M KRW) by year to add a trend chart and table.
Preview— the document below is saved as PDF/DOCX

Investment Review Report

코스모진텍

Business Reg. No. 2098125456 · CEO 마상혁

I.Investment Overview

Target코스모진텍 (2098125456)
Investment
Post-deal stake
ValuationPre — / Post —

II.Investment Highlights

No investment highlights written yet.

III.Investment Risks

No risks written yet.

IV.Company Profile

회사명코스모진텍
영문명Cosmo Genetech Co., LTD.
대표자마상혁
사업자등록번호2098125456
법인등록번호1101111968358
설립일2000.05.15
종업원수103명

V.Workforce

103

Current headcount · 2026.06 as of

VI.Financial Summary

Per DART disclosure · in 억/만원 (KRW)

Financial trend (100M KRW)

매출액100M KRW120.52021125.72022112.42023101.7202495.72025
영업이익100M KRW8.3202113.520226.12023-1.32024-22025
순이익100M KRW4.72021920223.12023-2.82024-2.62025
Item20252024202320222021
자산총계110.4억원112.6억원119.3억원124.6억원122.7억원
부채총계73.6억원73.2억원77.1억원85.4억원92.5억원
자본총계36.8억원39.4억원42.2억원39.2억원30.1억원
매출액95.7억원101.7억원112.4억원125.7억원120.5억원
영업이익-2억원-1.3억원6.1억원13.5억원8.3억원
순이익-2.6억원-2.8억원3.1억원9억원4.7억원

VII.Financial Ratios

FY2025 basis

-2.07%

영업이익률

-2.71%

순이익률

-2.35%

ROA

-7.05%

ROE

199.89%

부채비율

33.35%

자기자본비율

VIII.R&D Activity

Fields 농림수산식품 > 수산양식 · 농림수산식품 > 농생물학

Keywords 현장 적용 실용화, 베큘로바이러스, 질병 제어 신소재, 누에, 곤충세포

YearProjectsPapersPatents
2016100
2014100
2013100
2012100

IX.Valuation & Exit Plan

Exit valuation
Holding period5y
Enter exit assumptions (investment, stake, exit valuation, period) to see MOIC·IRR.

This report compiles disclosure & public data and AI-drafts some sections as a research aid. It is not investment advice; the user bears final responsibility for facts and investment decisions.

코스모진텍 투심보고서 | Alpha Lenz